SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-659006
Filing Date
2016-07-27
Accepted
2016-07-27 06:03:16
Documents
9
Period of Report
2016-07-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d199979d8k.htm 8-K 15492
2 EX-99.1 d199979dex991.htm EX-99.1 16408
3 EX-99.2 d199979dex992.htm EX-99.2 3992
4 GRAPHIC g199979ex99_2s1g1.jpg GRAPHIC 163193
5 GRAPHIC g199979ex99_2s2g1.jpg GRAPHIC 203423
6 GRAPHIC g199979ex99_2s3g1.jpg GRAPHIC 137610
7 GRAPHIC g199979ex99_2s4g1.jpg GRAPHIC 239596
8 GRAPHIC g199979ex99_2s5g1.jpg GRAPHIC 197992
9 GRAPHIC g199979img1.jpg GRAPHIC 13837
  Complete submission text file 0001193125-16-659006.txt   1353749
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 161785536
SIC: 2834 Pharmaceutical Preparations